Rheumatoid arthritis tumour necrosis factor inhibitors

[KeithD]

Tumor Necrosis Factor (TNF) inhibitors are a class of drugs used to treat autoimmune diseases such as rheumatoid arthritis (RA). TNF is a protein produced by the immune system that contributes to inflammation and joint damage in RA. TNF inhibitors work by blocking the action of TNF, reducing inflammation and slowing the progression of joint damage.

Common TNF inhibitors used to treat RA include:

1. Adalimumab (Humira)
   
2. Etanercept (Enbrel)
   
3. Infliximab (Remicade)
   
4. Golimumab (Simponi)
   
5. Certolizumab pegol (Cimzia)
   
   

These drugs are typically administered by injection or infusion and can be used alone or in combination with other RA medications.

TNF inhibitors have been shown to be effective in reducing pain, swelling, and disability in people with RA, but they may also have side effects and may not be suitable for everyone. It's important to discuss the risks and benefits of these drugs with your doctor before starting treatment.